Literature DB >> 26943797

[Bilateral amaurosis after spinal trauma].

R Schimmel1, H O Gümbel2, K J Lipke2.   

Abstract

This article presents the case of a 72-year-old male patient who suffered severe trauma of the spinal column. The patient developed persistent, bilateral, complete blindness after prolonged emergency neurosurgical treatment in a prone position. A bilateral surgical posterior ischemic optic neuropathy (PION) was diagnosed, which is a rare but severe complication of prolonged non-ocular surgery with circulatory stress. The massive, mostly bilateral, irreversible visual loss up to complete blindness leads to severe and permanent impairment of affected patients.

Entities:  

Keywords:  Complete blindness; Neurosurgery; Optic nerve; Posterior ischemic optic neuropathy; Visual acuity

Mesh:

Year:  2016        PMID: 26943797     DOI: 10.1007/s00347-016-0240-x

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

Review 1.  Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.

Authors:  S S Hayreh
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

2.  Perioperative visual loss in ocular and nonocular surgery.

Authors:  Kathleen T Berg; Andrew R Harrison; Michael S Lee
Journal:  Clin Ophthalmol       Date:  2010-06-24

Review 3.  Perioperative visual loss after nonocular surgeries.

Authors:  Nancy J Newman
Journal:  Am J Ophthalmol       Date:  2008-04       Impact factor: 5.258

Review 4.  Perioperative risk factors for posterior ischemic optic neuropathy.

Authors:  Stephan Dunker; Hugo Y Hsu; Jerry Sebag; Alfredo A Sadun
Journal:  J Am Coll Surg       Date:  2002-06       Impact factor: 6.113

Review 5.  Perioperative visual loss after spine surgery.

Authors:  Travis J Nickels; Mariel R Manlapaz; Ehab Farag
Journal:  World J Orthop       Date:  2014-04-18

6.  Management of ischemic optic neuropathies.

Authors:  Sohan Singh Hayreh
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.